In a society that has become obsessed with youth, there is a growing trend of young women, many still in their 20s, taking dramatic and expensive measures to stop the signs of aging before they happen with non-surgical treatments.

Preventive Botox injections and costly thermage, a hot radio frequency treatment that tightens and lifts skin that is all the rage among celebrities, are the latest cosmetic procedures used to stop crows feet in their tracks. Read More….

» A free CoolSculpting treatment
» Round trip tickets for two to New York City
» A shopping spree
» A day of beauty treatments from head to toe
» Dinners at the finest eateries in the city
» Accommodations at one of the city’s chicest boutique hotels
» $1,000 American Express Gift Card

Coolsculpting win a FREE Trip to NYC - Skin Perfect Medical

Sculptra Logo

Sculptra is now available at Skin Perfect.  We believe that more options means better outcomes for our patients.  Sculptra Aesthetic is different that your normal dermal filler.  This is the only injectable filler that shows improvement for up to 24 months through their initial FDA studies.  Call us today to learn more about this exciting anti-aging procedure.

The cool solution.

It’s called stubborn fat on purpose. Because no matter how much pain you put into eating healthy and exercise, there’s no gain. It’s virtually impossible to lose that muffin top and those love handles. You’re forced to just live with them or think surgery. Which is not cool by us, and exactly why we developed CoolSculpting^®.

Here’s the skinny: developed by Harvard scientists, our unique, patented, clinically proven procedure involves freezing fat cells without damage to your skin. There’s no knife. No suction hoses. No needles. No lasers, even. After your treatment, you get on with your busy day.

Save up to $450 on your favorite fillers! Expires Dec 31, 2010

Save $450 on Restylane or Perlane

]]> http://www.skinperfectmedical.com/blog/archives/357/feed 0 http://www.skinperfectmedical.com/blog/archives/349 http://www.skinperfectmedical.com/blog/archives/349#comments Tue, 12 Oct 2010 07:04:25 +0000 admin http://www.skinperfectmedical.com/blog/?p=349 Continue reading →]]>

FDA Grants Market Clearance for Erchonia’s Zerona Laser

Proven safe and effective for circumference reduction of the waist, hips and thighs
McKinney, TX August 30, 2010 – Erchonia Corporation, the world’s leading manufacturer in low-level laser technology, has been granted market clearance by the U.S. Food and Drug Administration for the non-invasive body contouring device, the Zerona. The Zerona is the first non-invasive aesthetic device to receive FDA market clearance in the U.S. for circumferential reduction of the waist, hips, and thighs.

The FDA granted market clearance following the completion of a placebo-controlled, randomized, double-blind, multi-site clinical investigation evaluating sixty-seven study participants. The results obtained from that study demonstrated an average inch loss reduction of 3.65 inches across patient’s waist, hips, and thighs in as little as two weeks. The clinical trial, absent of diet restrictions, exercise requirements, or any other adjunctive components properly illustrated the clinical utility of the Zerona and set the precedent on how aesthetic devices should be evaluated. READ MORE…

Clinical Results Show Efficacy Benefit with Dysport™ for Treatment of Crow’s Feet

ALEXANDRIA, VA (SEPTEMBER 24, 2010)

At the American Academy of Facial Plastic and Reconstructive Surgery annual meeting, clinical results were presented demonstrating a significant efficacy advantage with Dysport™ (abobotulinumtoxinA) over Botox^® Cosmetic (onabotulinumtoxinA) for the treatment of Crow’s feet.  The data were presented Friday, September 24 at a scientific session at the AAFPRS 2010 Annual Fall Meeting, taking place September 23-26 in Boston.The 90-subject study, titled “Internally Controlled Double-Blind Comparison of Onabotulinum and Abobotulinum Toxin Type A (Nettar, Kartik D., M.D., et. al),” met its primary endpoint (p=0.01) of greater efficacy of action with Dysport™ as defined by investigator assessment of maximum contraction at Day 30 post injection compared to Day 0.  Additionally, a secondary endpoint—subject assessment at maximum contraction at Day 30 compared to Day 0—also demonstrated statistical significance with Dysport™ (p=0.027).

“Botox has long been considered the gold standard of injectables, so this data showing Dysport’s stronger efficacy is compelling,” said Corey S. Maas, M.D., F.A.C.S., AAFPRS Group Vice President for Public and Regulatory Affairs.  “Since injectables are the non-surgical cosmetic procedure rising fastest in popularity, it is important to continue honing new applications for existing treatments.  Dysport’s potential here is exciting as Crow’s feet are a common concern for many men and women.”

READ MORE…